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Timing of Allergenic Food Introduction to the Infant Diet
and Risk of Allergic or Autoimmune Disease
A Systematic Review andMeta-analysis
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IMPORTANCE Timing of introduction of allergenic foods to the infant diet may influence the
risk of allergic or autoimmune disease, but the evidence for this has not been
comprehensively synthesized.
OBJECTIVE To systematically review andmeta-analyze evidence that timing of allergenic food
introduction during infancy influences risk of allergic or autoimmune disease.
DATA SOURCES MEDLINE, EMBASE,Web of Science, CENTRAL, and LILACS databases were
searched between January 1946 andMarch 2016.
STUDY SELECTION Intervention trials and observational studies that evaluated timing of
allergenic food introduction during the first year of life and reported allergic or autoimmune
disease or allergic sensitization were included.
DATA EXTRACTION AND SYNTHESIS Data were extracted in duplicate and synthesized for
meta-analysis using generic inverse variance or Mantel-Haenszel methods with a
random-effects model. GRADEwas used to assess the certainty of evidence.
MAIN OUTCOMES ANDMEASURES Wheeze, eczema, allergic rhinitis, food allergy, allergic
sensitization, type 1 diabetes mellitus, celiac disease, inflammatory bowel disease,
autoimmune thyroid disease, and juvenile rheumatoid arthritis.
RESULTS Of 16 289 original titles screened, data were extracted from 204 titles reporting 146
studies. There wasmoderate-certainty evidence from 5 trials (1915 participants) that early
egg introduction at 4 to 6months was associated with reduced egg allergy (risk ratio [RR],
0.56; 95% CI, 0.36-0.87; I2 = 36%; P = .009). Absolute risk reduction for a population with
5.4% incidence of egg allergy was 24 cases (95% CI, 7-35 cases) per 1000 population. There
wasmoderate-certainty evidence from 2 trials (1550 participants) that early peanut
introduction at 4 to 11 months was associated with reduced peanut allergy (RR, 0.29; 95% CI,
0.11-0.74; I2 = 66%; P = .009). Absolute risk reduction for a population with 2.5% incidence
of peanut allergy was 18 cases (95% CI, 6-22 cases) per 1000 population. Certainty of
evidence was downgraded because of imprecision of effect estimates and indirectness of the
populations and interventions studied. Timing of egg or peanut introduction was not
associated with risk of allergy to other foods. There was low- to very low-certainty evidence
that early fish introduction was associated with reduced allergic sensitization and rhinitis.
There was high-certainty evidence that timing of gluten introduction was not associated
with celiac disease risk, and timing of allergenic food introduction was not associated with
other outcomes.
CONCLUSIONS AND RELEVANCE In this systematic review, early egg or peanut introduction
to the infant diet was associated with lower risk of developing egg or peanut allergy.
These findings must be considered in the context of limitations in the primary studies.
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I ncreasing attentionhas focusedon the role of timingof in-troduction of allergenic food into the infant diet and riskof allergic andautoimmunediseases. Infant feedingguide-
lines havemoved away from advising parents to delay the in-
troduction of allergenic food, but most guidelines do not yet
advise early feeding of such foods.1-3 Several professional or-
ganizations have responded to recent research findings by is-
suing interim guidance advising early peanut introduction in
infants at high risk of peanut allergy, with some caveats.4,5
However, a randomized clinical trial of early introduction of
multiple allergenic foods did not show efficacy for prevent-
ing foodallergy,6andatrialofearlygluten introductionshowed
no effect on risk of celiac disease.7 The implications for pre-
venting food allergy or other immune-mediated health con-
ditions in the general population are not clear.
To informUKinfant feedingguidance,weundertookasys-
tematic review andmeta-analysis for the UK Food Standards
Agency, evaluating whether timing of allergenic food intro-
duction to the infant diet influences risk of allergic or autoim-
mune disease. This is one of a series of systematic reviews of
dietary exposures in pregnancy or infancy and immune out-
comes, the firstofwhich reviewedhydrolyzed infant formula.8
The immunological mechanisms underlying the different al-
lergic andautoimmunediseases vary. For example,most food
allergy ischaracterizedbyIgE-mediated inflammation,whereas
type 1 diabetesmellitus is caused by T cell–mediated islet cell
destruction.9,10However, thesediseases share a common fea-
ture of impaired immune tolerance, and immune function in
infancy may be modified by dietary exposures. Therefore, a
comprehensive range of allergic and autoimmune outcomes
were included.
Methods and Literature Search
Methods are described in the Supplement. This systematic
review is reported according to PRISMA guidance.11 We
searched the Cochrane Library, EMBASE, LILACS, MEDLINE,
Web of Science, and http://apps.who.int/trialsearch from
January 1, 1946, to March 8, 2016. Intervention trials and
observational studies evaluating age at allergenic food intro-
duction (milk, egg, fish, shellfish, tree nuts, wheat, peanuts,
soya)12 during the first year and allergic or autoimmune dis-
ease at any age were included. Other systematic reviews
rated as high quality using published criteria13 were also
included per the study protocol to avoid duplicating existing
work. When other systematic reviews were included, original
studies that were not captured by the other reviews were also
summarized. Outcomes evaluated were wheeze, eczema,
allergic rhinitis, food allergy (a reproducible hypersensitivity
reaction to a food), allergic sensitization (the presence of spe-
cific IgE to an allergen), type 1 diabetes mellitus, celiac dis-
ease, inflammatory bowel disease, juvenile rheumatoid
arthritis, psoriasis, and vitiligo.
Datawere extracted in duplicate and risk of bias assessed
using the Cochrane Risk of Bias tool and the National Insti-
tute for Clinical Excellence methodological checklists for in-
tervention and observational studies, respectively. Publica-
tion bias was assessed using funnel plots and the Egger test
when meta-analyses included at least 10 studies. Random-
effects meta-analyses used generic inverse variance and
Mantel-Haenszel methods for observational and interven-
tion studies, respectively.Heterogeneitywasquantifiedusing
the I2 statistic. Meta-analyses with I2>80% were not pooled.
For meta-analyses with more than 5 studies, we explored
heterogeneity in prespecified subgroup analyses of study de-
sign, risk of bias, risk of conflict of interest, and features of the
population, intervention, and outcome assessment. For
meta-analyses with 5 or fewer studies, we explored statisti-
cal heterogeneity descriptively and also conducted sensitiv-
ity analyses by study design and risk of bias for the key re-
view findings. The statistical programused formeta-analysis
wasR,version3.1.0 (RProject), andstatistical significancewas
set at 2-sided P<.05.
Post hoc trial sequential analysiswasused toquantify sta-
tistical reliability of moderate- or high-certainty review find-
ings using a 2-sided P<.05 significance level, 80%power, and
control event rates from included studies to estimate optimal
heterogeneity-adjusted and unadjusted information sizes
needed to identify relative risk reductions of 10%, 20%, and
30%. Trial sequential analysis quantifies statistical reliability
of data in a cumulativemeta-analysis in a similarway to an in-
terimanalysis in a single randomizedclinical trial. GRADEwas
used to assess certaintyof evidence, and theprotocolwas reg-
istered in PROSPERO.14 Ethical approval was not required by
the ImperialCollege JointResearchOffice.Thedata setandsta-
tistical code are available from the corresponding author.
Results
Search results are summarized in eFigure 1 (existing system-
atic reviews) and eFigure 2 (original studies) in the Supple-
ment. A summary of the findings of the 2 included system-
atic reviews is shown in eTables 1 and 2 in the Supplement.
Title, abstract, and full-text screening of original studies
yielded 146 eligible studies (204 separate titles). Overall, 24
intervention trials (39 titles) evaluated allergic outcomes in
13 298 participants and 5 intervention trials (6 titles) evalu-
ated autoimmune diseases in 5623 participants. Sixty-nine
Key Points
Question Does the timing of allergenic food introduction to
infants affect their risk of developing allergic or autoimmune
disease?
Findings There wasmoderate-certainty evidence that early
introduction of egg (from 4-6months) or peanut (from 4-11
months) was associated with reduced risk of egg or peanut
allergy, respectively. There was low- to very low-certainty
evidence that early fish introduction was associated with reduced
allergic sensitization and rhinitis and high-certainty evidence
that timing of gluten introduction was not associated with risk
of celiac disease.
Meaning Early introduction of egg or peanut to infants was
associated with a reduced risk of egg or peanut allergy.
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observational studies (90 titles) reported allergic outcomes in
142 103 participants and 48 observational studies (69 titles)
evaluated autoimmune diseases in 63 576 participants. No
study reported psoriasis or vitiligo. For allergic outcomes,
these included 55 cohort studies (1 retrospective), 2 nested
case-control studies, and 12 case-control or cross-sectional
studies. For autoimmune diseases, there were 7 cohort stud-
ies, 4 nested case-control studies, and 37 case-control stud-
ies. Characteristics of included studies are summarized in
eTables 3 and 4 (allergic outcomes) and eTables 5 and 6 (au-
toimmune outcomes) in the Supplement. More detailed char-
acteristics of the intervention studies of egg or peanut intro-
duction that reported egg or peanut allergy are shown in
Table 1 and Table 2.
Riskof biaswas low in4 (17%)of 24 intervention trials and
29 (42%) of 69 observational studies for allergic outcomes
(eTables 7 and 8 in the Supplement), and in 1 (20%) of 5 inter-
vention trials and 10 (21%) of 48 observational studies for au-
toimmuneoutcomes (eTables9and10 in theSupplement).The
main issues identifiedwere attritionbias in intervention trials
and lack of adjustment for potential confounders in observa-
tional studies.
The key findings of the systematic review are summa-
rized in Table 3, with GRADE evidence assessment summa-
rized in Table 4 and specific analyses for all positive or high-
certainty findings shown in Figure 1, Figure 2, and Figure 3.
More detailed methods and a summary of all findings are in
eTable 11 in the Supplement. The full report with a detailed
description of all findings including meta-analyses and
detailed methods is available on the UK Food Standards
Agency website (http://www.food.gov.uk/science/research
/allergy-research/fs305005) together with an associated
statement by the UK Committee on Toxicity of Chemicals in
Food, Consumer Products and the Environment (http://cot
.food.gov.uk/cotstatements).
Risk of Food Allergy and Allergic Sensitization
Fifteen intervention trials reported food allergy to any food
or to milk, egg, or peanut separately in 10 304 participants.
Seventeen trials reported allergic sensitization to any aller-
gen, aeroallergen, food allergen, egg, peanut, or milk in 7310
participants. A summary of findings is shown in eTable 11 in
the Supplement. Key findings for food allergy and allergic
sensitization to egg, peanut, or milk are summarized in
Figure 1, A and B.
Meta-analysis of 5 trials (1915 participants) showed evi-
dence that egg introduction at 4 to 6 months was associated
with lower risk of egg allergy compared with later egg intro-
duction (risk ratio [RR],0.56;95%CI,0.36-0.87;P = .009;mod-
erate heterogeneity [I2 = 36%]).6,15-18 Absolute risk reduction
forapopulationwith5.4%incidenceofeggallergywas24cases
(95% CI, 7-35 cases) per 1000 population. Meta-analysis of 4
trials (1786participants) showedno association between tim-
ing of egg introduction and egg sensitization.
Meta-analysis of 2 trials (1550 participants) showed evi-
dence that peanut introduction at age 4 to 11 months was
associated with lower risk of peanut allergy (RR, 0.29; 95%
CI, 0.11-0.74; P = .009; high heterogeneity [I2 = 66%]).4-6
Absolute risk reduction for a population with 2.5% incidence
of peanut allergy was 18 cases (95% CI, 6-22 cases) per 1000
population. One trial (640 participants) reported significantly
reduced allergic sensitization to peanut with early peanut
introduction, but numerical data were not reported; a second
trial (1168 participants) found no significant association
(Figure 1B).4,6
For several key findings, there was moderate to high sta-
tistical heterogeneity. For the egg introduction and egg
allergy analysis, heterogeneity was due to the abstract publi-
cation by Natsume and colleagues17—the authors declined to
share further information about their study. The study by
Perkin and colleagues,6 which used multiple allergenic food
introduction, had findings that were consistent with other
studies15,16,18 in which egg was the only allergenic food used.
For the egg introduction and egg sensitization analysis,
heterogeneity was due to the abstract publication by Bellach
and colleagues,16 which used specific IgE rather than
skin prick testing to determine egg sensitization. For the pea-
nut introduction and peanut allergy analysis, the high
heterogeneity was attributed to the high treatment adher-
ence in the study by Du Toit and colleagues4 compared with
more variable treatment adherence in the study by Perkin
and colleagues.6
In interventional studies, there was no association be-
tween timing of introduction of cow’s milk19,20 (Figure 1) or
other allergenic food and food allergy or allergic sensitization
and no association between timing of introduction of one al-
lergenic food and risk of food allergy or allergic sensitization
to a different food (eTable 11 in the Supplement).
Abstract publications made a significant contribution to
the analysis of egg introduction and egg allergy.However, the
findings were similar in sensitivity analyses excluding ab-
stract publications forwhich authorswereunable to share full
trial findings (eFigure3A in theSupplement)orexcludingstud-
ies at high or unclear risk of bias (eFigure 3B in the Supple-
ment). In sensitivity analyses of allergic sensitization that ex-
cluded abstracts (eFigure 4A in the Supplement) or studies at
highorunclear riskofbias (eFigure4BintheSupplement),early
egg introductionwasassociatedwithsignificantly reducedrisk
of allergic sensitization to egg.
Eighteen observational studies reported food allergy in
40 194 participants, and 20 studies reported allergic sensiti-
zation in 23466 participants. One prospective cohort study
(699 participants) found an association between early egg
introduction and decreased egg allergy (odds ratio [OR],
0.29; 95% CI, 0.15-0.56) and adjusted for possible reverse
causation.21 Three cohort studies (13472 participants), which
could not be meta-analyzed because of statistical heteroge-
neity and heterogeneity of analysis methods (Figure 2A),
found that early fish introduction (before age 6-9 months)
was associated with reduced allergic sensitization to any
allergen or food allergens.22-24 There was no association
between timing of introduction of other allergenic foods and
risk of food allergy or allergic sensitization. Assessment for
publication bias in analyses of food allergy and allergic sensi-
tization was not possible because of the limited number of
studies in each meta-analysis.
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Risk of Allergic Rhinitis
Thirteen intervention trials (6333 participants) and 12 obser-
vational studies (25 147 participants) reported allergic rhini-
tis. A summaryof findings is shown in eTable 11 in the Supple-
ment. Four cohort studies (12 781 participants) (Figure 2B)
found fish introduction before age 6 to 12 months was asso-
ciated with reduced allergic rhinitis at age 4 years or younger
(OR, 0.59; 95% CI, 0.40-0.87; high heterogeneity [I2 = 59%])
or at age 5 to 14 years (OR, 0.68; 95% CI, 0.47-0.98).22,23,25,26
In a sensitivity analysis excluding studies at high or unclear
risk of bias (eFigure 5 in the Supplement), the association be-
tween early fish introduction and reduced allergic rhinitis at
age 4 years or younger was not statistically significant. It was
not possible to explain the heterogeneity in the fish introduc-
tionandallergic rhinitis analysis. Inother interventionandob-
servational studies, timingof allergenic food introductionwas
notassociatedwith riskofallergic rhinitis.Assessment forpub-
licationbias in analyses of allergic rhinitiswasnotpossible be-
cause of the limited number of studies in eachmeta-analysis.
Risk ofWheeze
Sixteen intervention trials (8433 participants) and 30 obser-
vational studies (65601participants) reportedwheeze.Asum-
maryof findings is shownineTable 11 in theSupplement.Three
cohort studies (11 155 participants) found that fish introduc-
tion before age 8 to 12 months was associated with reduced
recurrentwheeze at age 4 years or younger (OR, 0.72; 95%CI,
0.59-0.87;noheterogeneity [I2 = 0%]).23,25,27However, 5other
studies (13033participants) foundnoassociationbetweentim-
ing of fish introduction and wheeze.28-32 In other interven-
tion and observational studies, there was no association be-
tween timing of allergenic food introduction and risk of
wheeze.Assessment forpublicationbias inanalysesofwheeze
was not possible because of the limited number of studies in
each meta-analysis.
Risk of Eczema
Seventeen intervention trials (6798 participants) and 37 ob-
servational studies (59 120 participants) reported eczema. A
summary of findings is shown in eTable 11 in the Supple-
ment.Formostanalysesof interventiontrials,dataweresparse;
for several analysesofobservational studies, statisticalhetero-
geneity was high. Overall, there was no consistent associa-
tion between timing of allergenic food introduction and risk
of eczema from either intervention or observational studies.
Assessment for publicationbias in analyses of eczemawasnot
possible because of the limited number of studies.
Risk of Autoimmune Diseases
Five intervention trials (5623 participants) and 48 observa-
tional studies (63576 participants) reported autoimmune dis-
ease, and 2 other systematic reviews of observational data
were identified. A summary of findings is shown in eTable 11
in the Supplement. The systematic reviews found no consis-
tent evidence for an association between timing of gluten
introduction and celiac disease.33,34 Intervention trials also
found no association between timing of gluten introduction
and celiac disease (Figure 3) or type 1 diabetes mellitus orTa
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milk introduction and type 1 diabetes mellitus.7,35-38 In sensi-
tivity analyses excluding studies at high or unclear risk of
bias (eFigure 6A in the Supplement) or only high risk of bias
(eFigure 6B in the Supplement), there was no association
between timing of gluten introduction and celiac disease. For
the gluten introduction and celiac disease analysis, heteroge-
neity was due to the study by Sellitto and colleagues37—in
this study, the control group had not yet ingested gluten at
the time of outcome assessment so celiac disease or serology
could not manifest.
Observational studies found no association between tim-
ing of gluten introduction and risk of celiac disease or inflam-
matory bowel disease; milk introduction and celiac disease or
juvenile idiopathic arthritis; or timing of allergenic food
Figure 1. Early Allergenic Food Introduction and Risk of Food Allergy or Food Sensitization
Weight (random-
effects model), %
Decreased Risk
of Food Allergy
Increased Risk
of Food Allergy
101.00.1
Risk Ratio (95% CI)
Dietary Introduction
of Allergenic Food
No. of
Events
Total
No.
Early
Outcome
Egg allergy
Risk Ratio
(95% CI)
No. of
Events
Total
No.
Late
Perkin et al,6 2016 30.921 569 32 596 0.69 (0.40-1.18)
16.75 60 23 61 0.22 (0.09-0.54)Natsume et al,17 2016
Peanut allergy
Perkin et al,6 2016 457 571 15 597 0.49 (0.20-1.19)
5510 312 54 313 0.19 (0.10-0.36)Du Toit et al,4 2015
18.28 130 13 124 0.59 (0.25-1.37)Tan et al,18 2016
3.12 142 1 156 2.20 (0.20-23.97)Bellach et al,16 2015
31.114 42 18 35 0.65 (0.38-1.11)Palmer et al,15 2013
Heterogeneity: I2 = 35.8%; P = .18
Random-effects model 100.0943 972 0.56 (0.36-0.87)
Heterogeneity: I2 = 66.1%; P = .09
Random-effects model 100883 910 0.29 (0.11-0.74)
Milk allergy
Perkin et al,6 2016 32.73 569 4 597 0.79 (0.18-3.50)
67.36 193 8 191 0.74 (0.26-2.10)Lowe et al,19 2011
Heterogeneity: I2 = 0%; P = .95
Random-effects model 100.0762 788 0.76 (0.32-1.78)
Risk of food allergyA
Weight (random-
effects model), %
Decreased Risk
of Allergic
Sensitization
Increased Risk
of Allergic
Sensitization
101.00.1
Risk Ratio (95% CI)
Dietary Introduction
of Allergenic Food
No. of
Events
Total
No.
Early
Outcome
Egg sensitization
Risk Ratio
(95% CI)
No. of
Events
Total
No.
Late
Perkin et al,6 2016 32.129 568 37 599 0.83 (0.52-1.33)
23.113 122 25 122 0.52 (0.28-0.97)Tan et al,18 2016
Peanut sensitization
Perkin et al,6 2016 100.022 569 34 599 0.68 (0.40-1.15)
8.58 142 4 156 2.20 (0.68-7.14)Bellach et al,16 2015
36.319 42 22 35 0.72 (0.47-1.09)Palmer et al,15 2013
Heterogeneity: I2 = 37%; P = .19
Random-effects model 100.0874 912 0.77 (0.53-1.11)
Milk sensitization
Perkin et al,6 2016 33.46 568 11 599 0.58 (0.21-1.55)
46.39 178 12 178 0.75 (0.32-1.74)Lowe et al,19 2011
20.44 25 4 23 0.92 (0.26-3.26)Kjellman and Johansson,20 1979
Heterogeneity: I2 = 0%; P = .84
Random-effects model 100.0771 800 0.72 (0.40-1.27)
Risk of allergic sensitizationB
Effect of early vs late dietary introduction of allergenic food (egg, milk, or
peanut) on risk of food allergy (A) or allergic sensitization (B) to the same food.
Data are from randomized clinical trials. “Event” refers to food allergy (A) or
allergic sensitization (B) to the same food. The size of the data markers is
proportional to study weights in themeta-analysis.
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introduction and risk of type 1 diabetes mellitus. There was
no evidence of publication bias in analyses of milk introduc-
tion and type 1 diabetes mellitus (P = .26 and P = .59 by Egger
test), and assessment for publication bias was not possible
for other comparisons because of the limited number of stud-
ies in each meta-analysis.
GRADE Evaluation of Certainty of Findings
Key findings were affected by the study of select popula-
tions with either active allergic disease, absence of allergic
sensitization to the intervention food, or both. There
was also significant variation between the populations stud-
ied in each trial. Interventions varied from early short-term
Figure 3. Early Gluten Introduction and Risk of Celiac Disease
Weight (random-
effects model), %
Decreased Risk
of Celiac Disease
Increased Risk
of Celiac Disease
101.00.1
Risk Ratio (95% CI)
Dietary Introduction of Gluten
No. of
Events
Total
No.
Early
Outcome
Risk Ratio
(95% CI)
No. of
Events
Total
No.
Late
Beyerlein et al,35 2014 18.014 77 8 73 1.66 (0.74-3.72)
43.153 328 64 379 0.96 (0.69-1.33)Lionetti et al,36 2014
36.844 475 36 465 1.20 (0.78-1.82)Vriezinga et al,7 2014
2.18 13 0 12 15.74 (1.01-245.35)Sellitto et al,37 2012
Heterogeneity: I2 = 46.1%; P = .13
Random-effects model 100.0893 929 1.22 (0.81-1.83)
Effect of early vs late dietary introduction of gluten on risk of celiac disease. Data are from randomized clinical trials. “Event” refers to celiac disease. The size of the
data markers is proportional to study weights in themeta-analysis.
Figure 2. Early Fish Introduction and Risk of Allergic Sensitization or Rhinitis
Decreased Risk
of Allergic
Sensitization
Increased Risk
of Allergic
Sensitization
101.00.1
Odds Ratio (95% CI)
No. of
Events
Total
No.Allergen
Odds Ratio
(95% CI)
Any allergen
1379 3675 0.71 (0.55-0.92)Nwaru et al,26 2013
612 2545 0.78 (0.64-0.95)Kull et al,23 2006
Any food
298 3636 0.59 (0.42-0.82)Alm et al,22 2011
Cow’s milk
515 3675 0.63 (0.44-0.90)Nwaru et al,26 2013
Egg
368 3675 0.64 (0.42-0.97)Nwaru et al,26 2013
881 3675 0.41 (0.25-0.67)Nwaru et al,24 2010
Any aeroallergen
153 3481 0.50 (0.33-0.76)Alm et al,22 2011
947 3675 0.66 (0.44-1.00)Nwaru et al,24 2010
92 552 1.19 (0.74-1.89)Zutavern et al,30 2004
Risk of allergic sensitizationA
Weight (random-
effects model), %
Decreased Risk
of Allergic
Rhinitis
Increased Risk
of Allergic
Rhinitis
101.00.1
Odds Ratio (95% CI)
No. of
Events
Total
No.Source
Odds Ratio
(95% CI)
Age at outcome = birth to 4 y
24.0246 4465 0.49 (0.27-0.89)Alm et al,22 2011
46.8373 3575 0.77 (0.61-0.97)Kull et al,23 2006
Age at outcome = 5 to 14 y
100442 3112 0.68 (0.47-0.98)Nwaru et al,26 2013
29.198 2271 0.45 (0.27-0.74)Nafstad et al,25 2003
1000.59 (0.40-0.87)Random-effects model
Risk of allergic rhinitisB
Heterogeneity: I2 = 59.2%; P = .09
Association between early dietary
introduction of fish and different
forms of allergic sensitization (A) or
allergic rhinitis (B). Data are from
observational studies. The size of the
data markers in panel B is
proportional to study weights in the
allergic rhinitis meta-analysis. Age
represents age at outcome
assessment.
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(3-4 days) introduction of an allergenic food to early sus-
tained introduction of single or multiple allergenic foods to
trials of delayed allergenic food introduction and multifac-
eted studies that also included other dietary components,
often together with environmental control measures such
as tobacco smoke and house dust mite avoidance. GRADE of
evidence was therefore reduced in several analyses because
of indirectness of the population or intervention (Table 4).
GRADE of evidence for the egg and peanut findings was also
reduced because of imprecise effect estimates but was
increased for peanut because of the strong effect size seen
in the trial of Du Toit and colleagues.4
Trial Sequential Analysis of Moderate- or High-Certainty
Findings
Peanut introduction and peanut allergy were not evaluated
using trial sequential analysis because of insufficient data in
themeta-analysis to estimate a sufficientnumberofpoints for
themonitoring boundaries. There were also insufficient data
toperformtrial sequential analysis for 10%or20%relative risk
reduction for other findings. Whether early egg introduction
wasassociatedwitha30%reduction in riskofeggallergyusing
trial sequential analysis was assessed. The heterogeneity-
adjusted andunadjusted optimal information sizes for detec-
tion of a 30% relative risk reduction for egg allergywere 8643
and 5239 study participants, respectively. Trial sequential
analysis for this outcome is shown ineFigures 7Aand7B in the
Supplement. Although the conventional line of statistical sig-
nificance was crossed (z = 1.96) in both analyses, the optimal
information size was not reached in either case. The cumula-
tive z score did not cross the monitoring boundary, although
it is close in unadjusted trial sequential analysis. It cannot be
confidently concluded that early egg introduction reduces egg
allergy by at least 30%; further trials are required to quantify
the treatment effect.
Trial sequential analysis was also used to evaluate
whether early gluten introduction increases celiac disease
risk by 30%. The heterogeneity-adjusted and unadjusted
optimal information sizes for detection of a 30% increase in
relative risk of celiac disease were 3599 and 9497 study par-
ticipants, respectively. Trial sequential analysis for this out-
come is shown in eFigures 7C and 7D in the Supplement. The
conventional line of statistical significance was not crossed
and the optimal information size was not reached. The
cumulative z score was close to the line of futility in unad-
justed trial sequential analysis. It cannot be confidently con-
cluded that further studies of timing of gluten introduction
and risk of celiac disease are futile.
Discussion
This systematic reviewfoundevidence that timingof introduc-
tion of certain allergenic foods to the infant diet was associ-
atedwithriskofallergicdiseasebutnot riskofautoimmunedis-
ease.Therewasmoderate-certaintyevidence that introduction
ofegg to the infantdietatage4to6monthswasassociatedwith
reduced egg allergy and introduction of peanut at age 4 to 11
monthswasassociatedwith reducedpeanut allergy compared
with later introduction of these foods. There was low-
certainty evidence that fish introduction before age 6 to 12
months was associatedwith reduced allergic rhinitis and very
low-certainty evidence that fish introduction before age 6 to 9
months was associated with reduced allergic sensitization.
The evidence base for a relationship between early aller-
genic food introduction and food allergy to the same food
was limited to a relatively small number of studies and
events and was only statistically significant for egg and pea-
nut. Heterogeneity-adjusted trial sequential analysis of early
egg introduction for egg allergy suggests that further trials
are warranted to confirm the findings and quantify the mag-
nitude of the treatment effect. Heterogeneity for egg intro-
duction was attributable to 1 small study presented in
abstract form only.13 Trial sequential analysis without adjust-
ment for heterogeneity showed stronger evidence that early
egg introduction reduced risk of egg allergy by 30% or more
but without crossing the trial sequential monitoring bound-
ary. Trial sequential analysis of early peanut introduction for
peanut allergy was not possible due to the small number of
studies and events in this analysis. The inability to undertake
trial sequential analysis for this outcome emphasizes the
value of further intervention studies of peanut introduction
and peanut allergy.39
These findings are consistent with a large body of experi-
mental data in various animal models in which early enteral
antigen exposure is established as effective for preventing al-
lergic sensitization to the same antigen.40 This phenomenon
of oral tolerance has not been directly shown to occur in hu-
mans until recently.4,41 Oral tolerance in humans appears to
be antigen specific, with no data showing early introduction
of one allergenic food influences the development of allergy
to a different allergenic food.
In contrast to egg and peanut allergy, this review found
that oral tolerance was not relevant to celiac disease, suggest-
ing that the findings may not be generalizable beyond food
allergy mediated by IgE antibodies. Trial sequential analysis
of gluten introduction and celiac disease risk found that fur-
ther trials would not be futile; however, available data show
no evidence of an association. Ongoing work is evaluating a
potential role for oral tolerance in other autoimmune dis-
eases; for example, the induction of immune tolerance to
insulin for preventing type 1 diabetes mellitus.42 There was
also no consistent evidence that early cow’s milk introduc-
tion influences risk of type 1 diabetes mellitus, which is con-
sistent with recent literature; for example, a trial of exten-
sively hydrolyzed vs intact infant formula showed no effect
on type 1 diabetes mellitus risk.43
There was lower-certainty evidence that early fish intro-
duction was associated with reduced allergic sensitization or
rhinitis. Sensitivity analysis of studies at low riskof bias found
that the association with allergic rhinitis at age 4 years or
younger was not statistically significant. One plausible bio-
logical mechanism is that early exposure to the anti-
inflammatory effects of omega-3 polyunsaturated fatty acids
present in fishmight influence development or expression of
allergic sensitization and associated inflammatory disease.44
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Thesedata conflictwithprevious recommendations tode-
lay introduction of allergenic foods to the infant diet and sug-
gest that current guidelines that donot advise early introduc-
tion of allergenic foods may need to be revised.1-3 They are,
however, consistentwith 1 recent intervention trial and a con-
sensus statement regarding introduction of peanut to the in-
fantdiet,4,5 andanydifferences inconclusions fromother trials
can be explained by the increased statistical power derived
frommeta-analysis.
Despite the comprehensive approach used in this review,
it was not possible to exclude clinically important effects in
mostanalysesbecause therewere fewstudies.Certaintyofevi-
dence was downgraded because of imprecision and indirect-
ness andvariation in interventionsusedandpopulations stud-
ied. However, there was not a clear difference in outcome
among studies of different populations inour analyses; for ex-
ample, inmeta-analysis of egg introduction and egg allergy, 3
studies undertaken in normal-risk, high-risk, and very high-
risk populations had similar findings. Risk-of-bias assess-
ment used different instruments for intervention and obser-
vational studies, which may not be directly comparable.
These systematic review findings should not automati-
cally lead to new recommendations to feed egg andpeanut to
all infants. The imprecise effect estimates, issues regarding in-
directness, and inconclusive trial sequential analysis find-
ings all need to be considered, together with a careful assess-
ment of the safety and acceptability of early egg and peanut
introduction in different populations.
Conclusions
In this systematic review, early introduction of egg or peanut
to the infant diet was associated with lower risk of develop-
ing egg or peanut allergy. These findings must be considered
in the context of limitations in the primary studies.
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